These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 11905546)

  • 1. DNA vaccine against malaria: a long way to go.
    Tuteja R
    Crit Rev Biochem Mol Biol; 2002; 37(1):29-54. PubMed ID: 11905546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards a blood-stage vaccine for malaria: are we following all the leads?
    Good MF
    Nat Rev Immunol; 2001 Nov; 1(2):117-25. PubMed ID: 11905819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parasite Recognition and Signaling Mechanisms in Innate Immune Responses to Malaria.
    Gowda DC; Wu X
    Front Immunol; 2018; 9():3006. PubMed ID: 30619355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
    Rainczuk A; Scorza T; Spithill TW; Smooker PM
    Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of a plasmid DNA vaccine encoding 42kDa fragment of Plasmodium vivax merozoite surface protein-1.
    Sheikh IH; Kaushal DC; Chandra D; Kaushal NA
    Acta Trop; 2016 Oct; 162():66-74. PubMed ID: 27311385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric parasites as tools to study Plasmodium immunology and assess malaria vaccines.
    Cockburn I
    Methods Mol Biol; 2013; 923():465-79. PubMed ID: 22990798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against malaria: targets, strategies and potentiation of immunity to blood stage parasites.
    Taylor-Robinson AW
    Front Biosci; 2000 Jan; 5():E16-29. PubMed ID: 10702381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism in liver-stage malaria vaccine candidate proteins: immune evasion and implications for vaccine design.
    Flanagan KL; Wilson KL; Plebanski M
    Expert Rev Vaccines; 2016; 15(3):389-99. PubMed ID: 26610026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination Strategies against Malaria: novel carrier(s) more than a tour de force.
    Tyagi RK; Garg NK; Sahu T
    J Control Release; 2012 Aug; 162(1):242-54. PubMed ID: 22564369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exoerythrocytic malaria vaccine development: understanding host-parasite immunobiology underscores strategic success.
    Taylor-Robinson AW
    Expert Rev Vaccines; 2002 Oct; 1(3):317-40. PubMed ID: 12901572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malaria vaccine: candidate antigens, mechanisms, constraints and prospects.
    Carvalho LJ; Daniel-Ribeiro CT; Goto H
    Scand J Immunol; 2002 Oct; 56(4):327-43. PubMed ID: 12234254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune effector mechanisms in malaria.
    Good MF; Doolan DL
    Curr Opin Immunol; 1999 Aug; 11(4):412-9. PubMed ID: 10448141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing immune responses against Plasmodium for rational vaccine design.
    Douradinha B; Doolan DL
    Trends Parasitol; 2011 Jun; 27(6):274-83. PubMed ID: 21531627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines. Searching for a parasite's weak spot.
    Taubes G
    Science; 2000 Oct; 290(5491):434-7. PubMed ID: 11183756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of strain-transcending immunity against Plasmodium chabaudi adami malaria with a multiepitope DNA vaccine.
    Scorza T; Grubb K; Smooker P; Rainczuk A; Proll D; Spithill TW
    Infect Immun; 2005 May; 73(5):2974-85. PubMed ID: 15845504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prime-and-Trap Malaria Vaccination To Generate Protective CD8
    Olsen TM; Stone BC; Chuenchob V; Murphy SC
    J Immunol; 2018 Oct; 201(7):1984-1993. PubMed ID: 30127085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development.
    Inoue M; Tang J; Miyakoda M; Kaneko O; Yui K; Culleton R
    Int J Parasitol; 2012 Aug; 42(9):859-70. PubMed ID: 22846785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering of Genetically Arrested Parasites (GAPs) For a Precision Malaria Vaccine.
    Kreutzfeld O; Müller K; Matuschewski K
    Front Cell Infect Microbiol; 2017; 7():198. PubMed ID: 28620583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-stage immunity for malaria vaccine development.
    Nahrendorf W; Scholzen A; Sauerwein RW; Langhorne J
    Vaccine; 2015 Dec; 33(52):7513-7. PubMed ID: 26469724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preerythrocytic malaria vaccine development.
    Mikolajczak SA; Aly AS; Kappe SH
    Curr Opin Infect Dis; 2007 Oct; 20(5):461-6. PubMed ID: 17762778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.